These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33797205)

  • 1. N-acetylcysteine for depression and glutamate changes in the left prefrontal cortex in adolescents and young adults at risk for bipolar disorder: A pilot study.
    Nery FG; Tallman MJ; Cecil KM; Blom TJ; Patino LR; Adler CM; DelBello MP
    Early Interv Psychiatry; 2022 Feb; 16(2):195-199. PubMed ID: 33797205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal proton spectroscopy study of the prefrontal cortex in youth at risk for bipolar disorder before and after their first mood episode.
    Nery FG; Weber WA; Blom TJ; Welge J; Patino LR; Strawn JR; Chu WJ; Adler CM; Komoroski RA; Strakowski SM; DelBello MP
    Bipolar Disord; 2019 Jun; 21(4):330-341. PubMed ID: 30864200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.
    McNamara RK; Strawn JR; Tallman MJ; Welge JA; Patino LR; Blom TJ; DelBello MP
    J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):293-305. PubMed ID: 32167792
    [No Abstract]   [Full Text] [Related]  

  • 4. Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot study.
    Zanetti MV; Otaduy MC; de Sousa RT; Gattaz WF; Busatto GF; Leite CC; Machado-Vieira R
    Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.
    Croarkin PE; Nakonezny PA; Wall CA; Murphy LL; Sampson SM; Frye MA; Port JD
    Psychiatry Res Neuroimaging; 2016 Jan; 247():25-33. PubMed ID: 26651598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual prediction of symptomatic converters in youth offspring of bipolar parents using proton magnetic resonance spectroscopy.
    Zhang W; Nery FG; Tallman MJ; Patino LR; Adler CM; Strawn JR; Fleck DE; Barzman DH; Sweeney JA; Strakowski SM; Lui S; DelBello MP
    Eur Child Adolesc Psychiatry; 2021 Jan; 30(1):55-64. PubMed ID: 32008167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
    Berk M; Turner A; Malhi GS; Ng CH; Cotton SM; Dodd S; Samuni Y; Tanious M; McAulay C; Dowling N; Sarris J; Owen L; Waterdrinker A; Smith D; Dean OM
    BMC Med; 2019 Jan; 17(1):18. PubMed ID: 30678686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
    Tomko RL; Gilmore AK; Gray KM
    Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom Profiles, But Not Prefrontal Neurochemistry, Differentiate ADHD Youth With and Without a Family History of Bipolar I Disorder.
    Chen C; Tallman MJ; Cecil KM; Patino LR; Blom TJ; DelBello MP; McNamara RK
    J Atten Disord; 2022 Nov; 26(13):1762-1773. PubMed ID: 35658594
    [No Abstract]   [Full Text] [Related]  

  • 10. N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study.
    Cullen KR; Klimes-Dougan B; Westlund Schreiner M; Carstedt P; Marka N; Nelson K; Miller MJ; Reigstad K; Westervelt A; Gunlicks-Stoessel M; Eberly LE
    J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):136-144. PubMed ID: 29053023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex.
    Patel NC; Cecil KM; Strakowski SM; Adler CM; DelBello MP
    J Child Adolesc Psychopharmacol; 2008 Dec; 18(6):623-7. PubMed ID: 19108667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
    Berk M; Dean O; Cotton SM; Gama CS; Kapczinski F; Fernandes BS; Kohlmann K; Jeavons S; Hewitt K; Allwang C; Cobb H; Bush AI; Schapkaitz I; Dodd S; Malhi GS
    J Affect Disord; 2011 Dec; 135(1-3):389-94. PubMed ID: 21719110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic Correlates of Bipolar Symptoms in Adolescents.
    Sonmez AI; Lewis CP; Port JD; Cabello-Arreola A; Blacker CJ; Seewoo BJ; McKean AJ; Leffler JM; Frye MA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):599-605. PubMed ID: 33179961
    [No Abstract]   [Full Text] [Related]  

  • 14. N-acetylcysteine for major depressive episodes in bipolar disorder.
    Magalhães PV; Dean OM; Bush AI; Copolov DL; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
    Braz J Psychiatry; 2011 Dec; 33(4):374-8. PubMed ID: 22189927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study.
    Strawn JR; Patel NC; Chu WJ; Lee JH; Adler CM; Kim MJ; Bryan HS; Alfieri DC; Welge JA; Blom TJ; Nandagopal JJ; Strakowski SM; DelBello MP
    J Am Acad Child Adolesc Psychiatry; 2012 Jun; 51(6):642-51. PubMed ID: 22632623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials.
    Nery FG; Li W; DelBello MP; Welge JA
    Bipolar Disord; 2021 Nov; 23(7):707-714. PubMed ID: 33354859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Pittas S; Theodoridis X; Haidich AB; Bozikas PV; Papazisis G
    Psychopharmacology (Berl); 2021 Jul; 238(7):1729-1736. PubMed ID: 33641060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of alterations in high energy phosphoryl compounds and intracellular pH in unmedicated adolescents with bipolar disorder.
    Weber WA; Dudley J; Lee JH; Strakowski SM; Adler CM; DelBello MP
    J Affect Disord; 2013 Sep; 150(3):1109-13. PubMed ID: 23706839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial.
    Bortolasci CC; Turner A; Mohebbi M; Liu ZS; Ashton M; Gray L; Marx W; Walker AJ; Kowalski GM; Jacka F; Berk M; Dean OM; Walder K
    J Psychiatr Res; 2021 Oct; 142():376-383. PubMed ID: 34438354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.